Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb 17;132(6):1960-5.
doi: 10.1021/ja908610s.

Protein modification, bioconjugation, and disulfide bridging using bromomaleimides

Affiliations
Free PMC article

Protein modification, bioconjugation, and disulfide bridging using bromomaleimides

Mark E B Smith et al. J Am Chem Soc. .
Free PMC article

Abstract

The maleimide motif is widely used for the selective chemical modification of cysteine residues in proteins. Despite widespread utilization, there are some potential limitations, including the irreversible nature of the reaction and, hence, the modification and the number of attachment positions. We conceived of a new class of maleimide which would address some of these limitations and provide new opportunities for protein modification. We report herein the use of mono- and dibromomaleimides for reversible cysteine modification and illustrate this on the SH2 domain of the Grb2 adaptor protein (L111C). After initial modification of a protein with a bromo- or dibromomaleimide, it is possible to add an equivalent of a second thiol to give further bioconjugation, demonstrating that bromomaleimides offer opportunities for up to three points of attachment. The resultant protein-maleimide products can be cleaved to regenerate the unmodified protein by addition of a phosphine or a large excess of a thiol. Furthermore, dibromomaleimide can insert into a disulfide bond, forming a maleimide bridge, and this is illustrated on the peptide hormone somatostatin. Fluorescein-labeled dibromomaleimide is synthesized and inserted into the disulfide to construct a fluorescent somatostatin analogue. These results highlight the significant potential for this new class of reagents in protein modification.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1. Modification of the Grb2 SH2 Domain (L111C) with N-Methylbromomaleimide
Scheme 2
Scheme 2. Conjugate Addition of Cysteine to Bromomaleimide Generates the Vicinal Bis-cysteine Adduct
Scheme 3
Scheme 3. Reversible Modification of the Grb2 SH2 Domain (L111C) 1 with Dibromomaleimide
Scheme 4
Scheme 4. Irreversible Modification of the Grb2 SH2 Domain (L111C) 1 with NEM
Figure 1
Figure 1
Relative reactivity of Grb2 SH2 domain (L111C) 1 with N-methylbromomaleimide, dibromomaleimide, and N-ethylmaleimide.
Scheme 5
Scheme 5. Cleavage of Grb2 SH2 Domain−Thioglucose Conjugate 6 under Intracellular-like Conditions
Scheme 6
Scheme 6. Reversible Modification of the Disulfide Bond of Somatostatin by Dibromomaleimide
Scheme 7
Scheme 7. Reversible Modification of the Disulfide Bond of Somatostatin by a Fluorescent Dibromomaleimide Reagent
Figure 2
Figure 2
Fluorescence measurements of samples excited at 488 nm.

Similar articles

Cited by

References

    1. Lundblad R. L.Chemical Reagents for Protein Modification, 3rd ed.; CRC Press: Boca Raton, FL, 2005.
    1. Chalker J. M.; Bernardes G. J. L.; Lin Y. A.; Davis B. G. Chem. Asian J. 2009, 4, 630–640. - PubMed
    1. Fodje M. N.; Al-Karadaghi S. Protein Eng. 2002, 15, 353–358. - PubMed
    1. Hermanson G. T.Bioconjugate Techniques; Academic Press: London, 1996.
    1. Schelte P.; Boeckler C.; Frisch B.; Schuber F. Bioconjugate Chem. 2000, 11, 118–123. - PubMed

Publication types